What happened
Telcon RF Pharmaceutical disclosed a private placement (third-party allotment) to raise US$2M, about 13.7% of its market value.
For context, this raise equals about 13.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$2M |
| vs. market value | 13.7% |
| Filed | 2026-04-07, Material event report (rights offering) |
| Source | DART rcept 20260407003323 → open original filing |
Source: DART. Information only, not investment advice.